Autopsy report · NCT01028313
A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease
Cause of deathSlow enrollment
“A decision was made to not move forward with the study. No participants were enrolled or treated.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- SCRI Development Innovations, LLC
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Graft-Versus-Host Disease
- Interventions
- LBH589; Methylprednisolone
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effect of an Intervention Based on Back School in an Aquatic Environment on Non-specific Low Back Pain
“The study was not initiated following an investigator decision not to proceed; no participants were enrolled.” - Robotic Versus Open Comparison in the Surgical Treatment of Wide Abdominal Wall heRnias (ROCSTAR)
“The study was not initiated and no participants were enrolled.” - Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation
“Study was not initiated. No subjects were screened or enrolled.” - Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
“Study did not begin, and no participants were enrolled.” - Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols Diet
“The study was withdrawn prior to initiation. No participants were enrolled.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.